[Suppression of concomitant thrombosis in central venous catheters (infraclavicular route) by salicylates (author's transl)].
The antithrombogenetic effects of salicylates (Colfarit) were studied to determine whether thrombosis due to the catheter could be reduced. 50 patients with vena-cavacatheters (infraclavicular route) were examined by phlebography. 25 patients received no antithrombotic medications and served as the control group. In these cases 35% showed evidence of thrombus formation. The remaining 25 patients received salicylates. By this measure catheter-induced thrombosis was reduced by 67%.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002404:Catheterization / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012459:Salicylates / Q000627:therapeutic use*; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*; D014684:Venae Cavae
D012459:Salicylates
Acetyl-salizylsäure (Colfarit) zur Suppression von Begleitthrombosen bei infraclaviculären Vena-Cava-Kathetern